Share on LinkedInShare on LinkedIn

ARTICLE · 15 JULY 2014

India Kept Out Of The Priority List By The US Trade Representative (USTR)

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices is a full-service law firm headquartered in Delhi NCR. The firm has 300+...

View firm profile
Explore more from S&A Law Offices

In one of the recent decision by the US trade representative, Indian IP should be kept away from the US IPR priority list.

IndiaIntellectual Property

In one of the recent decision by the US trade representative, Indian IP should be kept away from the US IPR priority list. This decision took place after the US industry had raised the matter of India's rejection of patents for Bristol-Myers Squibb's Sprycel and Novartis AG's Glivec. Intellectual Property Office, India has always maintained that its IPR regime is fully compliant with WTO norms and it would drag the US to the global trade body if any adverse unilateral step is taken against the country in IPR-related matters.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from